Erin Wright

Q: What is Erin Wright's success rate?

Erin Wright currently has a success rate of 91.09011468243754.

Q: What is the average return of Erin Wright's calls?

Their stock ratings have generated an average return of 7.845190059104453.

Morgan Stanley | Healthcare

Erin Wright is an analyst from Morgan Stanley specializing in the Healthcare sector. Ranked #1967 out of 4635 analysts, they have issued 46 stock ratings with a success rate of 91.09% and an average return of 7.85%.

Erin Wright has a well-established track record, with 46 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 91.09% and an average return of 7.85%, underscoring their expertise and ability to identify winning opportunities for investors.

#1967

Out of 4635

Total Ratings

+91.09%

Success Rate

+7.85%

Average Return

Recent Ratings Analysis

HSIC

Sell

Apr 24, 2026

Target

$64.00

Current

$78.22

Performance

—

Erin Wright rated HSIC as Underweight on Apr 24, 2026, setting a price target of 64. So far, the bearish outlook hasn’t materialized, with shares flat near 78.22.

NVST

Hold

Apr 24, 2026

Target

$21.00

Current

$27.04

Performance

—

On Apr 24, 2026, NVST was given a Equal-Weight rating by Erin Wright, with a target price of 21. Market indecision, reflected in sideways trading near 27.04, supported the cautious call.

MOH

Hold

Apr 24, 2026

Target

$146.00

Current

$174.51

Performance

—

MOH received a Equal-Weight rating from Erin Wright on Apr 24, 2026, aiming for 146. Shares remained flat at 174.51, aligning with the neutral rating.

ALGN

Hold

Apr 24, 2026

Target

$188.00

Current

$190.67

Performance

—

On Apr 24, 2026, Erin Wright published a Equal-Weight outlook on ALGN, with a target of 188. Sideways action left the Hold view intact, with no major move since 190.67.

PSX

Buy

Apr 24, 2026

Target

$174.00

Current

$159.53

Performance

—

Erin Wright on Apr 24, 2026 assigned PSX a Overweight rating, with a price target of 174. The recommendation remains pending validation as shares consolidate around 159.53.

UNH

Buy

Apr 22, 2026

Target

$395.00

Current

$354.56

Performance

0.29%

On Apr 22, 2026, Erin Wright reaffirmed UNH with a Overweight rating, targeting 395. Market indecision has kept the 395 target in a holding pattern.

BTSG

Buy

Mar 04, 2026

Target

$48.00

Current

$47.20

Performance

—

BTSG was rated Overweight by Erin Wright on Mar 04, 2026, with a price objective of 48. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

ELAN

Hold

Feb 25, 2026

Target

$24.00

Current

$22.38

Performance

-16.62%

On Feb 25, 2026, Erin Wright initiated coverage on ELAN with a Equal-Weight rating and target of 24. The rating matched the stock’s inability to hold above 22.38.

HUM

Sell

Feb 02, 2026

Target

$174.00

Current

$214.95

Performance

14.82%

Erin Wright issued a Underweight recommendation for HUM on Feb 02, 2026, price target set at 174. The bearish outlook played out, as shares fell from 214.95 to 214.95.

CAH

Buy

Jan 29, 2026

Target

$245.00

Current

$204.72

Performance

-3.08%

On Jan 29, 2026, CAH was evaluated by Erin Wright, who gave a Overweight rating and target of 245. So far, the Buy call awaits clearer momentum, with shares flat at 204.72.

COR

Buy

Jan 29, 2026

Target

$400.00

Current

$311.39

Performance

-11.56%

Erin Wright rated COR as Overweight on Jan 29, 2026, setting a price target of 400. The stock has underperformed, dropping 11.56% despite the bullish target of 400.

OPCH

Buy

Jan 13, 2026

Target

$38.00

Current

$28.54

Performance

-17.87%

On Jan 13, 2026, OPCH was given a Overweight rating by Erin Wright, with a target price of 38. Despite the Buy call, shares fell from 28.54 to 28.54, challenging the optimistic stance.

ELV

Hold

Dec 18, 2025

Target

$359.00

Current

$346.29

Performance

—

ELV received a Equal-Weight rating from Erin Wright on Dec 18, 2025, aiming for 359. Shares remained flat at 346.29, aligning with the neutral rating.

CVS

Buy

Dec 10, 2025

Target

$93.00

Current

$78.86

Performance

-0.14%

On Dec 10, 2025, Erin Wright published a Overweight outlook on CVS, with a target of 93. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 78.86.

ZTS

Buy

Nov 10, 2025

Target

$175.00

Current

$116.06

Performance

-3.11%

Erin Wright on Nov 10, 2025 assigned ZTS a Overweight rating, with a price target of 175. The recommendation remains pending validation as shares consolidate around 116.06.

MCK

Buy

Nov 06, 2025

Target

$916.00

Current

$836.10

Performance

-2.62%

On Nov 06, 2025, Erin Wright reaffirmed MCK with a Overweight rating, targeting 916. Market indecision has kept the 916 target in a holding pattern.

IDXX

Buy

Nov 04, 2025

Target

$805.00

Current

$560.93

Performance

-22.32%

IDXX was rated Overweight by Erin Wright on Nov 04, 2025, with a price objective of 805. This case shows how bullish projections can fail, with the stock now below 560.93.

PAHC

Hold

Jun 25, 2025

Target

$26.00

Current

$54.69

Performance

120.97%

On Jun 25, 2025, Erin Wright initiated coverage on PAHC with a Equal-Weight rating and target of 26. The Hold stance underestimated the stock’s strength as it gained 120.97%.

CI

Buy

Jan 31, 2025

Target

$379.00

Current

$279.72

Performance

-4.93%

Erin Wright issued a Overweight recommendation for CI on Jan 31, 2025, price target set at 379. The target of 379 remains in play, though confirmation will depend on future moves.

PDCO

Hold

Dec 17, 2024

Target

$31.35

Current

$31.33

Performance

1.39%

On Dec 17, 2024, PDCO was evaluated by Erin Wright, who gave a Equal-Weight rating and target of 31.35. Hold sentiment was validated by subdued trading with no breakout beyond 31.33.

XRAY

Buy

Dec 17, 2024

Target

$23.00

Current

$11.90

Performance

-37.99%

Erin Wright rated XRAY as Overweight on Dec 17, 2024, setting a price target of 23. The stock has underperformed, dropping 37.99% despite the bullish target of 23.

WBA

Sell

Oct 11, 2024

Target

$7.00

Current

$11.98

Performance

30.08%

On Oct 11, 2024, WBA was given a Underweight rating by Erin Wright, with a target price of 7. The Sell stance aligned with downward action, with the stock sliding from 11.98 to 11.98.

Frequency Asked Questions

Who is Erin Wright?

Erin Wright is an analyst from Morgan Stanley specializing in the Healthcare sector.

What is Erin Wright's success rate?

Erin Wright currently has a success rate of +91.09%.

How many ratings has Erin Wright issued?

Erin Wright has issued 46 stock ratings so far.

What is the average return of Erin Wright's calls?

Their stock ratings have generated an average return of +7.85%.

What is Erin Wright's ranking?

Erin Wright is ranked #1967 out of 4635 analysts.

What types of ratings does Erin Wright give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Erin Wright?

You can follow Erin Wright by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Erin Wright?

Their latest rating was a Sell on HSIC issued on 2026-04-24.